Atrial and Ventricular Leadless Pacemaker Implantation Using the Internal Jugular Vein: A Multicenter Experience
Pacing and Clinical Electrophysiology · 18.08.2026
DOI: 10.1111/pace.70400 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pacing and Clinical Electrophysiology, online erschienen am 18.08.2026. Verfasst von Dilesh Patel und 14 weiteren Autor:innen. Beteiligte Einrichtung: TriHealth Heart & Vascular Institute, Hatton Research Institute, Bethesda North Hospital, Cincinnati, Ohio, USA. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
Background
Prior reports of internal jugular vein (IJV) access for implantation of leadless pacemakers (LLPM) are primarily small series and for ventricular LLPM.
Objectives
To describe outcomes of consecutive patients undergoing IJV access for both atrial and ventricular LLPM implantation.
Methods
This observational multicenter study included 32 consecutive patients (17 female; 69 ± 14 years; range 17–91) undergoing LLPM implantation via IJV access. Dual chamber LLPM was implanted in 16 patients, right ventricular (RV) only in 13, and right atrial (RA) only in 3. Electrical parameters were measured at implantation, 7–10 days post implantation, and at last follow‐up (mean 215 ± 98 days).
Results
IJV access was successful in all patients. Mean procedure and fluoroscopy times were 82 ± 40 and 16 ± 9 min, respectively. RV implant required 1.3 ± 0.6 deployments with mean of 21 min and RA implant required 1.6 ± 0.9 deployments with mean of 31 min. Electrical parameters were excellent. Current of injury for the RA LLPM is the primary indicator of engagement of the atrial myocardium. Two device‐related complications occurred without clinical sequelae; no late complications were observed. Fifteen patients were discharged the same day.
Conclusions
IJV access for atrial and ventricular LLPM implantation is safe and effective across a broad age range and is an alternative to FV access, enabling same‐day discharge and early ambulation. Elevated acute atrial capture thresholds with robust current of injury should not prompt repositioning, as thresholds significantly improve at early follow‐up.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- TriHealth Heart & Vascular Institute, Hatton Research Institute, Bethesda North Hospital, Cincinnati, Ohio, USA.
- University of California Davis Medical Center, Sacramento, California, USA.
- Baptist Health Lexington, Lexington, Kentucky, USA.
- Abbott Laboratories, Abbott Park, Illinois, USA.
ORCID-Profile: Daniel Cortez, John J Lee, Emile G Daoud
Zitieren
APA
Patel, D., Cortez, D., Lee, J. J., Gandhi, G., Shah, H., Winner, M., Canterbury, A., Athar, M., Zamani, T., Seijari, M. N., Gandhi, E., Athar, F., Clippinger, B., Schwartz, E., & Daoud, E. G. (2026). Atrial and Ventricular Leadless Pacemaker Implantation Using the Internal Jugular Vein: A Multicenter Experience. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.70400
Vancouver
Patel D, Cortez D, Lee JJ, Gandhi G, Shah H, Winner M, et al. Atrial and Ventricular Leadless Pacemaker Implantation Using the Internal Jugular Vein: A Multicenter Experience. Pacing and Clinical Electrophysiology. 2026. doi:10.1111/pace.70400
BibTeX
@article{Patel2026,
author = {Patel, Dilesh and Cortez, Daniel and Lee, John J and Gandhi, Gaurang and Shah, Hemal and Winner, Marshall and Canterbury, Ann and Athar, Muhammad and Zamani, Taraneh and Seijari, Mohammed Najdat and Gandhi, Eshaan and Athar, Fawaad and Clippinger, Bryan and Schwartz, Evan and Daoud, Emile G},
title = {Atrial and Ventricular Leadless Pacemaker Implantation Using the Internal Jugular Vein: A Multicenter Experience},
journal = {Pacing and Clinical Electrophysiology},
year = {2026},
doi = {10.1111/pace.70400}
}
EUVIMED